PMC:7306567 / 16378-16620 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"183","span":{"begin":22,"end":35},"obj":"Chemical"},{"id":"184","span":{"begin":66,"end":72},"obj":"Chemical"},{"id":"185","span":{"begin":88,"end":102},"obj":"Chemical"},{"id":"186","span":{"begin":104,"end":109},"obj":"Chemical"},{"id":"187","span":{"begin":141,"end":146},"obj":"Chemical"},{"id":"188","span":{"begin":199,"end":204},"obj":"Chemical"}],"attributes":[{"id":"A183","pred":"tao:has_database_id","subj":"183","obj":"MESH:D054714"},{"id":"A184","pred":"tao:has_database_id","subj":"184","obj":"MESH:D001393"},{"id":"A185","pred":"tao:has_database_id","subj":"185","obj":"MESH:D000666"},{"id":"A186","pred":"tao:has_database_id","subj":"186","obj":"MESH:C068538"},{"id":"A187","pred":"tao:has_database_id","subj":"187","obj":"MESH:D001393"},{"id":"A188","pred":"tao:has_database_id","subj":"188","obj":"MESH:C068538"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Other options include echinocandins in combination with anti-mold azoles, and liposomal amphotericin B (L-AmB) in regions with high rates of azole-resistant A. fumigatus, although clinical data with L-AmB in ICU patients are limited [43, 44]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T103","span":{"begin":101,"end":102},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T104","span":{"begin":104,"end":109},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9940"},{"id":"T105","span":{"begin":157,"end":158},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T106","span":{"begin":199,"end":204},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9940"}],"text":"Other options include echinocandins in combination with anti-mold azoles, and liposomal amphotericin B (L-AmB) in regions with high rates of azole-resistant A. fumigatus, although clinical data with L-AmB in ICU patients are limited [43, 44]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T107","span":{"begin":22,"end":35},"obj":"Chemical"},{"id":"T108","span":{"begin":66,"end":72},"obj":"Chemical"},{"id":"T109","span":{"begin":88,"end":102},"obj":"Chemical"},{"id":"T110","span":{"begin":141,"end":146},"obj":"Chemical"}],"attributes":[{"id":"A107","pred":"chebi_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/CHEBI_57248"},{"id":"A108","pred":"chebi_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/CHEBI_68452"},{"id":"A109","pred":"chebi_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/CHEBI_2682"},{"id":"A110","pred":"chebi_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/CHEBI_68452"}],"text":"Other options include echinocandins in combination with anti-mold azoles, and liposomal amphotericin B (L-AmB) in regions with high rates of azole-resistant A. fumigatus, although clinical data with L-AmB in ICU patients are limited [43, 44]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T110","span":{"begin":0,"end":242},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Other options include echinocandins in combination with anti-mold azoles, and liposomal amphotericin B (L-AmB) in regions with high rates of azole-resistant A. fumigatus, although clinical data with L-AmB in ICU patients are limited [43, 44]."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T123","span":{"begin":22,"end":35},"obj":"CHEBI:57248;CHEBI:57248"},{"id":"T124","span":{"begin":88,"end":102},"obj":"CHEBI:2682;CHEBI:2682"},{"id":"T125","span":{"begin":141,"end":146},"obj":"CHEBI:68452;CHEBI:68452"},{"id":"T126","span":{"begin":158,"end":169},"obj":"NCBITaxon:31032"},{"id":"T2586","span":{"begin":22,"end":35},"obj":"CHEBI:57248;CHEBI:57248"},{"id":"T84468","span":{"begin":88,"end":102},"obj":"CHEBI:2682;CHEBI:2682"},{"id":"T79778","span":{"begin":141,"end":146},"obj":"CHEBI:68452;CHEBI:68452"},{"id":"T89235","span":{"begin":158,"end":169},"obj":"NCBITaxon:31032"}],"text":"Other options include echinocandins in combination with anti-mold azoles, and liposomal amphotericin B (L-AmB) in regions with high rates of azole-resistant A. fumigatus, although clinical data with L-AmB in ICU patients are limited [43, 44]."}

{"project":"2_test","denotations":[{"id":"32572532-29544767-47963436","span":{"begin":234,"end":236},"obj":"29544767"},{"id":"32572532-26282594-47963437","span":{"begin":238,"end":240},"obj":"26282594"},{"id":"T78250","span":{"begin":234,"end":236},"obj":"29544767"},{"id":"T9616","span":{"begin":238,"end":240},"obj":"26282594"}],"text":"Other options include echinocandins in combination with anti-mold azoles, and liposomal amphotericin B (L-AmB) in regions with high rates of azole-resistant A. fumigatus, although clinical data with L-AmB in ICU patients are limited [43, 44]."}